Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assemblies
Established bacterial glycoengineering platforms limit access to protein and glycan substrates. Here the authors design a cytoplasmic protein glycosylation system, Glycoli, to generate a variety of multivalent glycostructures.
Enregistré dans:
Auteurs principaux: | Hanne L. P. Tytgat, Chia-wei Lin, Mikail D. Levasseur, Markus B. Tomek, Christoph Rutschmann, Jacqueline Mock, Nora Liebscher, Naohiro Terasaka, Yusuke Azuma, Michael Wetter, Martin F. Bachmann, Donald Hilvert, Markus Aebi, Timothy G. Keys |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ac3f91e741e14ae68b947f045f6333f3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Direct quality control of glycoengineered erythropoietin variants
par: Tomislav Čaval, et autres
Publié: (2018) -
A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host
par: Christian M. Harding, et autres
Publié: (2019) -
Glycoengineering of EphA4 Fc leads to a unique, long-acting and broad spectrum, Eph receptor therapeutic antagonist
par: Cassandra L. Pegg, et autres
Publié: (2017) -
Modulation of Epstein-Barr Virus Glycoprotein B (gB) Fusion Activity by the gB Cytoplasmic Tail Domain
par: Nicholas J. Garcia, et autres
Publié: (2013) -
De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist
par: Yamato Komatsu, et autres
Publié: (2021)